VANCOUVER, British Columbia / Jul 04, 2025 / Business Wire / WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the “Company” or “WELL”), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that at its annual general meeting held June 30, 2025 (the “Meeting”), all of the nominees for election as directors of the Company referred to in its notice of meeting and information circular dated May 28, 2025 for the Meeting were elected.
A total of 67,105,724 common shares representing 26.52% of the outstanding common shares of the Company were voted by proxy at the Meeting. Voting results for the election of directors at the Meeting were as follows:
Resolution | Vote Type | Total Votes | % Voted | |||
Kenneth Cawkell | For | 55,319,811 | 82.45% | |||
John Kim | For | 63,350,632 0 | 94.42% | |||
Sybil E Jen Lau | For | 65,493,814 0 1,602,030 | 97.61% 0% 2.39% | |||
Thomas Liston | For | 58,911,074 0 8,184,770 | 87.80% 0% 12.20% | |||
Tara McCarville | For | 58,713,637 0 8,382,207 | 87.51% 0% 12.49% | |||
Hamed Shahbazi | For | 49,082,859 0 18,012,985 | 73.15% 0% 26.85% |
The results of other matters considered at the Meeting are reported in the Report of Voting Results as filed on SEDAR+ (www.sedarplus.ca) filed on July 4, 2025.
WELL HEALTH TECHNOLOGIES CORP.
Per: “Hamed Shahbazi”
Hamed Shahbazi
Chief Executive Officer, Chairman and Director
About WELL Health Technologies Corp.
WELL’s mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL’s comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. WELL’s solutions enable more than 42,000 healthcare providers between the US and Canada and power the largest owned and operated healthcare ecosystem in Canada with more than 210 clinics supporting primary care, specialized care, and diagnostic services. In the United States WELL’s solutions are focused on specialized markets such as the gastrointestinal market, women’s health, primary care, and mental health. WELL is publicly traded on the Toronto Stock Exchange under the symbol “WELL” and on the OTC Exchange under the symbol “WHTCF”. To learn more about the Company, please visit: www.well.company.
| Last Trade: | C$3.78 |
| Daily Change: | -0.16 -4.06 |
| Daily Volume: | 3,639,416 |
| Market Cap: | C$959.670M |
October 31, 2025 September 25, 2025 | |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
